TATA Health (01255.HK) receives additional resumption guidance from the Hong Kong Stock Exchange

The China Fortune Financial APP News reported that TATA Health (01255.HK) issued an announcement on September 12, 2025, stating that the company received a letter from the Hong Kong Stock Exchange. The letter listed additional guidelines for the resumption of trading of the company's shares on the Stock Exchange. Specifically, the company must conduct an independent internal control review and demonstrate that it has established sufficient internal controls and procedures to meet its responsibilities under the listing rules.